Compare ELMD & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELMD | SMTI |
|---|---|---|
| Founded | 1992 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 326.9M | 313.5M |
| IPO Year | 2010 | 2008 |
| Metric | ELMD | SMTI |
|---|---|---|
| Price | $39.45 | $34.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $36.00 | $34.00 |
| AVG Volume (30 Days) | 48.1K | ★ 425.7K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 46.55 | N/A |
| EPS | ★ 0.91 | N/A |
| Revenue | ★ $54,716,000.00 | $15,586,976.00 |
| Revenue This Year | $15.59 | $17.31 |
| Revenue Next Year | $11.51 | $12.48 |
| P/E Ratio | $43.96 | ★ N/A |
| Revenue Growth | 13.83 | ★ 32.47 |
| 52 Week Low | $19.93 | $16.05 |
| 52 Week High | $47.40 | $35.70 |
| Indicator | ELMD | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 44.85 | 79.57 |
| Support Level | $35.61 | $33.68 |
| Resistance Level | $43.61 | N/A |
| Average True Range (ATR) | 1.41 | 0.22 |
| MACD | -0.22 | -0.28 |
| Stochastic Oscillator | 19.53 | 95.77 |
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.